Page 3 - Alza Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alza corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alza Corporation Today - Breaking & Trending Today

BioSpace Movers & Shakers, Dec. 18


Published: Dec 18, 2020
By Alex Keown
Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk. ....

New York , United States , Rockefeller University , United Kingdom , Terri Gaskell , Peter Greenleaf , Scott Burger , Andrea Heslin Smiley , Eli Lilly , Jeffrey Vacira , Manny Triggiano , Dmitri Daveynis , Michael Weinblatt , N Manisha Shetty Gulati , Mervyn Turner , Sandip Kapadia , D Martin Carter , Djordje Filipovic , Perry Calias , Siemens Healthineers , Marylyn Rigby , Daphne Karydas , Badreddin Edris , David Enloe , Jeff Myers , Stanley Cohen ,

Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations


Published: Dec 15, 2020
SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced the appointment of Christopher (Chris) Kurtz as executive vice president of technical operations. Mr. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development.
“We are pleased to welcome Chris to our leadership team at such a pivotal time for our antifungal and antiviral programs,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “Chris’s leadership and deep manufacturing expertise, delivering both biologic and small molecule drugs to market, will be invaluable as we advance rezafungin, currently in pivotal Phase 3 trials ....

United States , San Diego , Christopher Chris Kurtz , Cloudbreak Avcs , Karen Oshea , Jeffrey Stein , Brian Ritchie , Gilead Sciences , Nektar Therapeutics , Cidara Therapeutics Inc , Us Navy Submarine , Alza Corporation , Exchange Commission , G Nuclear Engineering Program , University Of Colorado , Lifesci Communications , Securities Exchange , Novo Nordisk , Nuclear Engineering , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , கிறிஸ்டோபர் கிறிஸ் கர்ட்ஸ் ,